ORAMED PHARMACEUTICALS INC. - 29 Jan 2026 SCHEDULE 13D Report for Nano Dimension Ltd. Ordinary Shares, par value NIS 5.00 per share (NNDM)

Filing Manager
ORAMED PHARMACEUTICALS INC.
Reporting Manager
Nadav Kidron
Security
Nano Dimension Ltd. Ordinary Shares, par value NIS 5.00 per share
Symbol
NNDM
Shares outstanding
210,988,600 shares
Disclosed Ownership
10,549,430 shares
Ownership
5%
Form type
SCHEDULE 13D
Filing time
29 Jan 2026, 16:44:36 UTC
Date of event
29 Jan 2026
Next filing
19 Feb 2026
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Oramed Pharmaceuticals Inc. 5% 10,413,730 0 10,413,730 /s/ Avraham Gabay Avraham Gabay, Chief Financial Officer 0001176309
Nadav Kidron 5% 10,549,430 135,700 10,413,730 /s/ Nadav Kidron Nadav Kidron 0001351779